Autor: |
Raziel, Arie, Herman, Arie, Bukovsky, Ian, Caspi, Eliahu, Ron-el, Raphael, Raziel, A, Herman, A, Bukovsky, I, Caspi, E, Ron-el, R |
Předmět: |
|
Zdroj: |
Human Reproduction; Apr1996, Vol. 11 Issue 4, p711-715, 5p |
Abstrakt: |
Intravenous immunoglobulins, first given to recurrent aborters with anti-phospholipid syndrome, have been administered to unexplained aborters since 1986. They probably have immunomodulatory properties beyond supplying blocking antibodies. When pregnancy was confirmed, women were started with a loading dose which was repeated every 3–4 weeks until the second trimester. Dosages were empirical. Pregnancy rates ranged between 50 and 82%. The main maternal complications, i.e., allergic reactions and infections, were rare. [ABSTRACT FROM PUBLISHER] |
Databáze: |
Complementary Index |
Externí odkaz: |
|